Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Liver Neoplasms"" wg kryterium: Temat


Tytuł :
In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
Autorzy :
Mamdouh AM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Horus University - Egypt, New Damietta 34518, Egypt.
Khodeer DM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt. Electronic address: .
Tantawy MA; Hormones Department, Medical Research Division, National Research Centre, Cairo, Egypt; Stem Cells Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo, Egypt.
Moustafa YM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt; Faculty of Pharmacy, BUC, Cairo, Egypt.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Nov 15; Vol. 285, pp. 119961. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Protocols*
Amygdalin/*therapeutic use
Antibiotics, Antineoplastic/*therapeutic use
Antineoplastic Agents, Phytogenic/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Doxorubicin/*therapeutic use
Liver Neoplasms/*drug therapy
Metformin/*therapeutic use
Animals ; Biomarkers, Tumor/blood ; Carcinoma, Hepatocellular/pathology ; Diethylnitrosamine ; Hep G2 Cells ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/chemically induced ; Male ; Prognosis ; Rats ; Rats, Wistar ; alpha-Fetoproteins/analysis
Czasopismo naukowe
Tytuł :
ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.
Autorzy :
Chen B; Affiliated Cancer Hospital & Institute and Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes, Guangzhou Medical University, Guangzhou, 910095, China.
Cha JH; Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, 22212, South Korea; Department of Biomedical Science and Engineering, Graduate School, Inha University, Incheon, 22212, South Korea.
Yan M; Department of Pathology, Harbin Medical University, Harbin, 150081, China.
Cao N; Department of General Surgery, Nanjing Lishui People's Hospital, Nanjing, 211200, China.
Ye P; Affiliated Cancer Hospital & Institute and Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes, Guangzhou Medical University, Guangzhou, 910095, China.
Yan X; Affiliated Cancer Hospital & Institute and Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes, Guangzhou Medical University, Guangzhou, 910095, China. Electronic address: .
Yang WH; Affiliated Cancer Hospital & Institute and Key Laboratory of Cell Homeostasis and Cancer Research of Guangdong Higher Education Institutes, Guangzhou Medical University, Guangzhou, 910095, China; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Oct 08; Vol. 573, pp. 1-8. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
Transcription Factors/*metabolism
Animals ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/pathology ; Cells, Cultured ; Down-Regulation/drug effects ; Female ; Humans ; Hypoglycemic Agents/pharmacology ; Liver Neoplasms/drug therapy ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/metabolism ; Liver Neoplasms, Experimental/pathology ; Metformin/pharmacology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Transcription Factors/antagonists & inhibitors ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł :
Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
Autorzy :
Zhao L; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Liang L; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Guo M; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Li M; School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Yu X; School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Wang Y; School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Wang Y; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Pokaż więcej
Źródło :
Current topics in medicinal chemistry [Curr Top Med Chem] 2021 Oct 05; Vol. 21 (14), pp. 1268-1284.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Phytogenic/*pharmacokinetics
Carcinoma, Hepatocellular/*drug therapy
Glycyrrhetinic Acid/*chemistry
Liver Neoplasms/*drug therapy
Magnetite Nanoparticles/*chemistry
Nanoparticles/*chemistry
Paclitaxel/*pharmacokinetics
Animals ; Antineoplastic Agents, Phytogenic/chemistry ; Apoptosis/drug effects ; Carcinoma, Hepatocellular/pathology ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Hep G2 Cells ; Humans ; Liposomes/chemistry ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/pathology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Paclitaxel/chemistry ; Particle Size
Czasopismo naukowe
Tytuł :
Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1.
Autorzy :
Li YT; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei 100, Taiwan.
Wu HL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei 100, Taiwan.
Liu CJ; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei 100, Taiwan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 29; Vol. 22 (17). Date of Electronic Publication: 2021 Aug 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Hepatocellular/*virology
Hepatitis B/*pathology
Liver Neoplasms/*virology
Repressor Proteins/*metabolism
Trans-Activators/*metabolism
Animals ; Carcinoma, Hepatocellular/pathology ; Hepatitis B/complications ; Hepatitis B virus/genetics ; Hepatitis B virus/pathogenicity ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/virology ; Marmota ; Mice ; Mice, Transgenic ; Repressor Proteins/chemistry ; Trans-Activators/chemistry
Czasopismo naukowe
Tytuł :
Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure-Activity Relationship Analysis.
Autorzy :
Kant R; Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Yang MH; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan.
Tseng CH; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Yen CH; Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Li WY; Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Tyan YC; Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen M; Department of Urology, Mackay Memorial Hospital, Taipei 10449, Taiwan.
Tzeng CC; Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen WC; Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
You K; Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Wang WC; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County 35053, Taiwan.
Chen YL; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen YA; Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Pokaż więcej
Źródło :
Journal of medicinal chemistry [J Med Chem] 2021 Jul 08; Vol. 64 (13), pp. 8992-9009. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Discovery*
High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Glycine N-Methyltransferase/*genetics
Liver Neoplasms/*drug therapy
Proto-Oncogene Proteins c-myc/*antagonists & inhibitors
Administration, Oral ; Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/chemistry ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Female ; Glycine N-Methyltransferase/metabolism ; Humans ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/metabolism ; Liver Neoplasms, Experimental/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Molecular Structure ; Promoter Regions, Genetic/drug effects ; Promoter Regions, Genetic/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Structure-Activity Relationship ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
A remotely controlled NIR-II photothermal-sensitive transgene system for hepatocellular carcinoma synergistic therapy.
Autorzy :
Qiao S; School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, People's Republic of China and The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, People's Republic of China.
Xin F; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. .
Wu M; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Zheng Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Zhao B; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Zhang C; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Liu X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, People's Republic of China and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Wei Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China.
Liu J; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China. , Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, People's Republic of China and Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, People's Republic of China and Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou 350014, P. R. China.
Pokaż więcej
Źródło :
Journal of materials chemistry. B [J Mater Chem B] 2021 Jun 30; Vol. 9 (25), pp. 5083-5091.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Photothermal Therapy*
Antineoplastic Agents/*pharmacology
Biocompatible Materials/*pharmacology
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Photosensitizing Agents/*pharmacology
Adsorption ; Animals ; Antineoplastic Agents/chemistry ; Apoptosis/drug effects ; Biocompatible Materials/chemistry ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Drug Screening Assays, Antitumor ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/pathology ; Mice ; Optical Imaging ; Photosensitizing Agents/chemistry
Czasopismo naukowe
Tytuł :
c-Myc-driven Hepatocarcinogenesis.
Autorzy :
Moon H; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Gyeonggi-do, Republic of Korea.
Park H; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Gyeonggi-do, Republic of Korea.; Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Gyeonggi-do, Republic of Korea.
Ro SW; Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Gyeonggi-do, Republic of Korea; .; Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Gyeonggi-do, Republic of Korea.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 4937-4946.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinogenesis/*pathology
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Liver Neoplasms, Experimental/*pathology
Proto-Oncogene Proteins c-myc/*metabolism
Tumor Suppressor Protein p53/*metabolism
Animals ; Apoptosis ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Cell Proliferation ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Liver Neoplasms, Experimental/genetics ; Liver Neoplasms, Experimental/metabolism ; Mice ; Mice, Inbred C57BL ; Proto-Oncogene Proteins c-myc/genetics ; Tumor Cells, Cultured ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Tytuł :
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
Autorzy :
Park DJ; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Sung PS; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Lee GW; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Cho S; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Kim SM; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Kang BY; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Hur W; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Yang H; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul 03383, Korea.
Lee SK; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Lee SH; Department of Clinical Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Jung ES; Department of Hospital Pathology, College of Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul 03383, Korea.
Seo CH; Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Ahn J; Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Choi HJ; Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
You YK; Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Jang JW; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Bae SH; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul 03383, Korea.
Choi JY; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Yoon SK; The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 29; Vol. 22 (9). Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Immunological/*pharmacology
B7-H1 Antigen/*biosynthesis
Carcinoma, Hepatocellular/*immunology
Immune Checkpoint Inhibitors/*pharmacology
Immunotherapy/*methods
Liver Neoplasms/*immunology
Molecular Targeted Therapy/*methods
Neoplasm Proteins/*biosynthesis
Nivolumab/*pharmacology
Tumor Microenvironment/*immunology
Tumor-Associated Macrophages/*metabolism
Animals ; Antineoplastic Agents, Immunological/therapeutic use ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/genetics ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Coculture Techniques ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Ki-67 Antigen/biosynthesis ; Ki-67 Antigen/genetics ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Liver Neoplasms, Experimental/immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Mice ; Mice, Inbred C57BL ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasm Proteins/genetics ; Nivolumab/therapeutic use ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Tumor Cells, Cultured ; Tumor-Associated Macrophages/drug effects
Czasopismo naukowe
Tytuł :
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.
Autorzy :
Zhou G; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Da Won Bae S; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Nguyen R; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Huo X; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Han S; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Zhang Z; Renal Inflammation and Immunology Group, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, 230601, Anhui, China.
Hebbard L; Discipline of Molecular and Cell Biology, Australian Institute for Tropical Health and Medicine, Centre for Molecular Therapeutics, James Cook University, Townsville, 4811, Australia.
Duan W; School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, Victoria, 3217, Australia.
Eslam M; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Liddle C; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia.
Yuen L; Department of Surgery, Westmead Hospital, Westmead, NSW, 2145, Australia.
Lam V; Department of Surgery, Westmead Hospital, Westmead, NSW, 2145, Australia.
Qiao L; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia. Electronic address: .
George J; Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Westmead, NSW, 2145, Australia. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Mar 31; Vol. 501, pp. 124-132. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
AC133 Antigen/*genetics
Aptamers, Nucleotide/*administration & dosage
Carcinoma, Hepatocellular/*drug therapy
Doxorubicin/*administration & dosage
Liver Neoplasms/*drug therapy
Neoplastic Stem Cells/*drug effects
Animals ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/pharmacokinetics ; Aptamers, Nucleotide/genetics ; Aptamers, Nucleotide/pharmacokinetics ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Doxorubicin/pharmacokinetics ; Drug Carriers/administration & dosage ; Drug Carriers/pharmacokinetics ; Drug Delivery Systems/methods ; HEK293 Cells ; Humans ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/metabolism ; Liver Neoplasms, Experimental/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology
Czasopismo naukowe
Tytuł :
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.
Autorzy :
Song JS; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Chang CC; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Wu CH; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Dinh TK; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Jan JJ; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Huang KW; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Chou MC; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Shiue TY; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Yeh KC; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Ke YY; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Yeh TK; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Ta YN; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Lee CJ; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Huang JK; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China.
Sung YC; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China.
Shia KS; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, Republic of China; .
Chen Y; Institute of Biomedical Engineering and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing Hua University, 30013 Hsinchu, Taiwan, Republic of China .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 30; Vol. 118 (13).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Receptors, CXCR4/*antagonists & inhibitors
Animals ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Diethylnitrosamine/administration & dosage ; Diethylnitrosamine/toxicity ; Drug Synergism ; Humans ; Liver Neoplasms/immunology ; Liver Neoplasms/pathology ; Liver Neoplasms, Experimental/chemically induced ; Liver Neoplasms, Experimental/drug therapy ; Liver Neoplasms, Experimental/immunology ; Liver Neoplasms, Experimental/pathology ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Male ; Mice ; Molecular Docking Simulation ; Rats ; Receptors, CXCR4/metabolism ; Signal Transduction/drug effects ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/immunology ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Tumor-Associated Macrophages/drug effects ; Tumor-Associated Macrophages/immunology ; Tumor-Associated Macrophages/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
The Apoptotic Effect of Trichinella spiralis Infection Against Experimentally Induced Hepatocellular Carcinoma.
Autorzy :
Elhasawy FA; Department of Medical Parasitology, Faculty of Medicine, Tanta University, Egypt.
Ashour DS; Department of Medical Parasitology, Faculty of Medicine, Tanta University, Egypt.
Elsaka AM; Department of Pathology, Faculty of Medicine, Tanta University, Egypt.
Ismail HI; Department of Medical Parasitology, Faculty of Medicine, Tanta University, Egypt.
Pokaż więcej
Źródło :
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2021 Mar 01; Vol. 22 (3), pp. 935-946. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Apoptosis*
Biological Therapy*
Trichinella spiralis*
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms, Experimental/*pathology
Trichinellosis/*pathology
Animals ; Carcinoma, Hepatocellular/therapy ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Liver Neoplasms, Experimental/therapy ; Rats
Czasopismo naukowe
Tytuł :
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
Autorzy :
Wang Q; The First Affiliated Hospital of Soochow University, Suzhou, China.
Jiang Y; The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhu Q; The First Affiliated Hospital of Soochow University, Suzhou, China.
Duan Y; The First Affiliated Hospital of Soochow University, Suzhou, China.
Chen X; The First Affiliated Hospital of Soochow University, Suzhou, China.
Xu T; The First Affiliated Hospital of Soochow University, Suzhou, China.
Jin Z; The First Affiliated Hospital of Soochow University, Suzhou, China.
Li C; The First Affiliated Hospital of Soochow University, Suzhou, China.
Wu D; The First Affiliated Hospital of Soochow University, Suzhou, China.
Huang H; The First Affiliated Hospital of Soochow University, Suzhou, China. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Nov; Vol. 147 (11), pp. 3441-3445. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Intraepithelial Lymphocytes/*pathology
Liver Neoplasms/*pathology
Liver Neoplasms/*therapy
Lymphoma, T-Cell, Peripheral/*pathology
Lymphoma, T-Cell, Peripheral/*therapy
Splenic Neoplasms/*pathology
Splenic Neoplasms/*therapy
Adolescent ; Adult ; Aminopyridines/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Benzamides/administration & dosage ; Bortezomib/administration & dosage ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Hematopoietic Stem Cell Transplantation ; Humans ; Intraepithelial Lymphocytes/immunology ; Liver Neoplasms/drug therapy ; Liver Neoplasms/immunology ; Lymphoma, T-Cell, Peripheral/drug therapy ; Lymphoma, T-Cell, Peripheral/immunology ; Middle Aged ; Prednisolone/administration & dosage ; Retrospective Studies ; Splenic Neoplasms/drug therapy ; Splenic Neoplasms/immunology ; Treatment Outcome ; Vincristine/administration & dosage ; Young Adult
SCR Protocol :
VAP-cyclo protocol
Czasopismo naukowe
Tytuł :
Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
Autorzy :
Tsai YC; Department of Radiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan.
Shih JH; Department of Genetics, Stanford University School of Medicine, Stanford University, Stanford, CA, 94305, USA.
Hwang HE; Department of Radiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan.
Chiu NC; Department of Radiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan.
Lee RC; Department of Radiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan.
Tseng HS; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan.; Department of Medical Imaging, Cheng Hsin General Hospital, No. 45, Cheng Hsin St., Beitou District, Taipei, Taiwan.
Liu CA; Department of Radiology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan. .; School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sec. 2, Linong Street, Taipei, 112, Taiwan. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Oct; Vol. 31 (10), pp. 7464-7475. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/therapy
Chemoembolization, Therapeutic*
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/therapy
Cone-Beam Computed Tomography ; Ethiodized Oil ; Humans ; Neoplasm Recurrence, Local ; Reproducibility of Results ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication.
Autorzy :
Fernández JÁ; Department of Surgery and Organ Transplantation. Virgen de la Arrixaca University Hospital. Ctra. Madrid-Cartagena s/n, 30120 Murcia Spain; Biomedical Research Institute of Murcia (IMIB-Arrixaca). Campus de Ciencias de la Salud. Ctra. Buenavista s/n, 30120 Murcia Spain.
Alconchel F; Department of Surgery and Organ Transplantation. Virgen de la Arrixaca University Hospital. Ctra. Madrid-Cartagena s/n, 30120 Murcia Spain; Biomedical Research Institute of Murcia (IMIB-Arrixaca). Campus de Ciencias de la Salud. Ctra. Buenavista s/n, 30120 Murcia Spain. Electronic address: .
Gómez B; Department of Surgery and Organ Transplantation. Virgen de la Arrixaca University Hospital. Ctra. Madrid-Cartagena s/n, 30120 Murcia Spain; Biomedical Research Institute of Murcia (IMIB-Arrixaca). Campus de Ciencias de la Salud. Ctra. Buenavista s/n, 30120 Murcia Spain.
Martínez J; Department of Clinical Oncology. Virgen de la Arrixaca University Hospital. Ctra. Madrid-Cartagena s/n, 30120 Murcia Spain; Biomedical Research Institute of Murcia (IMIB-Arrixaca). Campus de Ciencias de la Salud. Ctra. Buenavista s/n, 30120 Murcia Spain.
Ramírez P; Department of Surgery and Organ Transplantation. Virgen de la Arrixaca University Hospital. Ctra. Madrid-Cartagena s/n, 30120 Murcia Spain; Biomedical Research Institute of Murcia (IMIB-Arrixaca). Campus de Ciencias de la Salud. Ctra. Buenavista s/n, 30120 Murcia Spain.
Pokaż więcej
Źródło :
International journal of surgery (London, England) [Int J Surg] 2021 Oct; Vol. 94, pp. 106126. Date of Electronic Publication: 2021 Sep 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Gastrointestinal Stromal Tumors*/drug therapy
Gastrointestinal Stromal Tumors*/surgery
Liver Neoplasms*/drug therapy
Liver Neoplasms*/surgery
Liver Transplantation*
Humans ; Imatinib Mesylate/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł :
Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases.
Autorzy :
Borello A; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy. Electronic address: .
Russolillo N; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy.
Lo Tesoriere R; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy.
Langella S; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy.
Guerra M; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy.
Ferrero A; Department of General and Oncological Surgery, Mauriziano Hospital, Largo Turati 62, 10128, Turin, Italy.
Pokaż więcej
Źródło :
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland [Surgeon] 2021 Oct; Vol. 19 (5), pp. e140-e145. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Journal Article
MeSH Terms :
Colorectal Neoplasms*/diagnostic imaging
Colorectal Neoplasms*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Liver Neoplasms*/surgery
Fluorodeoxyglucose F18 ; Humans ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Radiopharmaceuticals ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Autorzy :
Shi T; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan.
Morishita A; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan.
Kobara H; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan.
Masaki T; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki 761-0793, Japan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Sep 30; Vol. 22 (19). Date of Electronic Publication: 2021 Sep 30.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Hepatocellular/*blood
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*blood
Liver Neoplasms/*genetics
MicroRNAs/*blood
MicroRNAs/*genetics
RNA, Long Noncoding/*blood
RNA, Long Noncoding/*genetics
Tumor Microenvironment/*genetics
Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/pathology ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Liver Neoplasms/diagnosis ; Liver Neoplasms/pathology ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.
Autorzy :
Okamoto H; Department of Surgery, Tsuru Municipal Hospital, Yamanashi, Japan; .; Department of Gastrointestinal & Breast, Endocrine Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Shiba S; Department of Surgery, Tsuru Municipal Hospital, Yamanashi, Japan.; Department of Gastrointestinal & Breast, Endocrine Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Iino H; Department of Gastrointestinal & Breast, Endocrine Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.; Department of Surgery, Kofu Municipal Hospital, Yamanashi, Japan.
Sudoh M; Department of Gastrointestinal & Breast, Endocrine Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Ichikawa D; Department of Gastrointestinal & Breast, Endocrine Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Sep; Vol. 41 (9), pp. 4505-4513.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Colorectal Neoplasms/*drug therapy
Liver Neoplasms/*drug therapy
Liver Neoplasms/*secondary
Adult ; Aged ; Aged, 80 and over ; Antigens, CD34/metabolism ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Camptothecin/analogs & derivatives ; Camptothecin/pharmacology ; Camptothecin/therapeutic use ; Colorectal Neoplasms/diagnostic imaging ; Colorectal Neoplasms/metabolism ; Computed Tomography Angiography ; Female ; Fluorouracil/pharmacology ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/pharmacology ; Leucovorin/therapeutic use ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Organoplatinum Compounds/pharmacology ; Organoplatinum Compounds/therapeutic use ; Retrospective Studies ; Survival Analysis ; Treatment Outcome ; Tumor Microenvironment/drug effects
SCR Protocol :
Folfox protocol; IFL protocol
Czasopismo naukowe
Tytuł :
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
Autorzy :
Kang HJ; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Kim H; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Lee DH; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Hur BY; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Hwang YJ; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Suh KS; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Han JK; From the Departments of Radiology (H.J.K., D.H.L., J.K.H.) and Pathology (H.K., Y.J.H.), Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 03080, Korea; Departments of Radiology (H.J.K., D.H.L., J.K.H.), Pathology (H.K., Y.J.H.), and Surgery (K.S.S.), Seoul National University College of Medicine, Seoul, Korea; and Department of Radiology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea (B.Y.H.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2021 Sep; Vol. 300 (3), pp. 572-582. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*diagnostic imaging
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*diagnostic imaging
Liver Neoplasms/*surgery
Magnetic Resonance Imaging/*methods
Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Contrast Media ; Female ; Gadolinium DTPA ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Postoperative Period ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
Autorzy :
Serrano PE; Department of Surgery, 153004McMaster University, Canada.; Ontario Clinical Oncology Group, McMaster University, Canada.
Gu CS; Ontario Clinical Oncology Group, McMaster University, Canada.; Department of Oncology, 152999McMaster University, Canada.
Moulton CA; 30133University Health Network, Canada.
Gallinger S; 30133University Health Network, Canada.
Pokaż więcej
Źródło :
The American surgeon [Am Surg] 2021 Sep; Vol. 87 (9), pp. 1431-1437. Date of Electronic Publication: 2020 Dec 20.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Tomography, X-Ray Computed*
Colorectal Neoplasms/*pathology
Liver Neoplasms/*diagnostic imaging
Liver Neoplasms/*surgery
Neoplasms, Multiple Primary/*diagnostic imaging
Neoplasms, Multiple Primary/*surgery
Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/mortality ; Female ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Neoplasms, Multiple Primary/mortality ; Prospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
Autorzy :
Laimer G; Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Jaschke N; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.; Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technical University of Dresden, Fetscherstr. 74, 01037, Dresden, Germany.
Schullian P; Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Putzer D; Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Eberle G; Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Solbiati M; R&D Unit, R.A.W. Srl, Milan, Italy.
Solbiati L; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Milan, Italy.
Goldberg SN; Department of Radiology, Hadassah Hebrew University Medical Centre, Jerusalem, Israel.; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Bale R; Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Sep; Vol. 31 (9), pp. 6489-6499. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Catheter Ablation*
Colorectal Neoplasms*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Radiofrequency Ablation*
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Margins of Excision ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies